Board approves preferential issue of shares and warrants worth about Rs 33 crore

Board & Shareholder Meetings View source PDF

SHIVALIK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+9.9%1-day move

₹242.00

prior close

₹253.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

——+0.1—+9.9—————————

Up moveDown movePending

AI summary

Board approved preferential issue of up to 3,72,000 equity shares at Rs 250 each (about Rs 9.30 crore) to 5 public allottees, and up to 9,48,000 fully convertible warrants at Rs 250 each (about Rs 23.70 crore) to promoter Growel Remedies and 2 others. EGM set for August 20, 2026.

Likely market impact

Equity dilution possible if approved; potential about Rs 33 crore capital raise pending shareholder nod on August 20.